Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03598270
Title	Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer (ANITA)
Acronym	ANITA
Recruitment	Completed
Gender	female
Phase	Phase III
Variant Requirements	No
Sponsors	Grupo Espanol de Investigacion en Cancer de Ovario
Indications	fallopian tube carcinoma peritoneal carcinoma endometrioid ovary carcinoma ovarian serous carcinoma
Therapies	Carboplatin + Gemcitabine Niraparib Carboplatin + Pegylated liposomal doxorubicin Atezolizumab + Carboplatin + Pegylated liposomal doxorubicin Atezolizumab + Carboplatin + Gemcitabine Atezolizumab + Carboplatin + Paclitaxel Carboplatin + Paclitaxel Atezolizumab + Niraparib
Age Groups:	adult \| senior
Covered Countries	ITA \| FRA \| ESP \| DEU \| BEL